Mechanistic description
The HSP90 chaperone system, comprising HSP90AA1 and HSP90AB1 in complex with their cochaperones STIP1 (Stress-Induced Phosphoprotein 1) and AHSA1 (AHA1 activator of HSP90 ATPase), operates through a distinct mechanism that stabilizes intermediate misfolded conformations rather than directly recognizing exposed amyloidogenic segments. This alternative quality control pathway targets proteins in pre-amyloidogenic states where native structure is compromised but β-sheet rich amyloid cores have not yet formed. HSP90’s unique ATP-driven conformational cycle creates a molecular clamp that encapsulates partially misfolded substrates, preventing their progression toward aggregation-competent states. STIP1 functions as a critical adaptor protein that bridges HSP70 and HSP90 systems, transferring substrates from initial HSP70-mediated recognition to HSP90-dependent stabilization of salvageable conformers. AHSA1 accelerates HSP90’s ATPase activity and prolongs the closed, substrate-encapsulating conformation, effectively quarantining misfolded proteins in a kinetically stable intermediate state. This mechanism explains how cells can maintain pools of stress-damaged proteins in non-toxic conformations during proteostatic stress, preventing both aggregation and premature degradation. The HSP90 system shows particular selectivity for substrates with disrupted tertiary structure but intact secondary structure elements, representing a complementary recognition code to HSP70’s preference for exposed hydrophobic segments. This temporal segregation of chaperone function—HSP90 acting on earlier misfolding intermediates while HSP70 targets later amyloidogenic states—provides a multi-tiered defense against protein aggregation diseases.
Mechanism / pathway
- HSP90AA1, HSP90AB1, STIP1, AHSA1
- HSP90-cochaperone stabilization pathway
- protein biochemistry
Evidence for (9)
HSP70 preferentially binds α-synuclein at N-terminal and NAC regions
J-domain proteins enhance HSP70 affinity for amyloid cores
HSP70 suppresses early nucleation steps in aggregation kinetics
HSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation.
LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.
HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease.
Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment.
Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
HSP90 ATPase cycle creates a closed-clamp conformation that physically encapsulates partially misfolded substrates, preventing their progression to aggregation-competent states
Evidence against (2)
HSP70's broad specificity predicts high-affinity binding to any exposed hydrophobic segment—this conflates 'prefers misfolded' with 'distinguishes pathologic from physiologic misfolded states'
Transient native-state fluctuations expose hydrophobic segments during normal folding—this predicts HSP70 would 'waste' cycles on normal substrates
Evidence matrix
Supporting
- HSP70 preferentially binds α-synuclein at N-terminal and NAC regions PMID:29463785
- J-domain proteins enhance HSP70 affinity for amyloid cores PMID:33902342
- HSP70 suppresses early nucleation steps in aggregation kinetics PMID:33427873
- HSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation. PMID:37580406 · 2023 · Cell Res
- LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. PMID:37469132 · 2023 · Autophagy
- HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease. PMID:36246562 · 2022 · Dis Markers
- Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment. PMID:26960140 · 2016 · PLoS One
- Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease. PMID:31733664 · 2019 · Int Rev Neurobiol
- HSP90 ATPase cycle creates a closed-clamp conformation that physically encapsulates partially misfolded substrates, preventing their progression to aggregation-competent states PMID:31399574
Contradicting
- HSP70's broad specificity predicts high-affinity binding to any exposed hydrophobic segment—this conflates 'prefers misfolded' with 'distinguishes pathologic from physiologic misfolded states'
- Transient native-state fluctuations expose hydrophobic segments during normal folding—this predicts HSP70 would 'waste' cycles on normal substrates
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). HSP90-cochaperone complexes preferentially stabilize intermediate misfolded sta…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-var-1a15a9a02f
@misc{scidex_hypothesis_hvar1a15,
title = {HSP90-cochaperone complexes preferentially stabilize intermediate misfolded sta…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-var-1a15a9a02f},
note = {SciDEX artifact hypothesis:h-var-1a15a9a02f}
}